Search results
Results from the Health.Zone Content Network
Heart problems are a very rare side effect of COVID-19 vaccines. More common side effects are mild and temporary, including: fever. pain and soreness at injection site. fatigue. headache. chills ...
COVID-19 vaccines are now FDA approved for those ages 5 and up. Here are some of the side effects reported by age. Children. FDA approval of the COVID-19 vaccine for children ages 5 to 11 happened ...
Denmark started vaccinating against COVID-19 on 27 December 2020. [1] Vaccination in Denmark is free of cost and voluntary. [1] It is available to all residents of Denmark and those from abroad staying for more than 30 days in Denmark. [1] Denmark has one of the highest levels of COVID-19 vaccination in the European Union as of the end of ...
People aged 12 and above who got coronavirus vaccines before September 12, 2022: 1 dose of any of the 3 newer vaccines; Children aged 5-11, regardless of previous vaccine status: 1 dose of Pfizer ...
The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. [1] The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).
The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a ...
The four types of COVID-19 vaccines being used around the world are: messenger RNA (mRNA) vaccines. viral vector vaccines. protein subunit vaccines. whole virus vaccines. The table below provides ...
Egypt received 50,000 doses of the Sinopharm BIBP vaccine on 10 December 2020, followed by 50,000 doses of the AstraZeneca vaccine on 31 January 2021. In February, March and May 2021, Egypt received 1.1 million doses of the Sinopharm BIBP vaccine and 2.55 million doses of the Oxford–AstraZeneca vaccine.